Women’s health beyond reproduction: meeting the challenges

Bull World Health Organ 2012;90:478–478A | doi:10.2471/BLT.12.103549 Editorials 478 Women’s health and noncommunicable diseases are both generating increasing interest within the international com- munity. Over the past two years major action platforms have been launched in these areas, including the United Nations’ Global Strategy for Women’s and Children’s Health and the Political Declaration of the High-level Meeting of the General Assembly on the Preven- tion and Control of Non-communicable Diseases. However, the intersection and relationships between the two areas have not been adequately explored and, as a result, the health needs of women beyond reproduction remain largely unaddressed. Strong historical ties between the concept of women’s health and that of reproductive health have led to a concentration of international atten- tion and resources on maternal health and human immunodeficiency virus infection, especially in low- and middle- income countries. Fruitful results have been reaped, yet women’s health is not limited to women’s reproductive capac- ity; it extends throughout the life-cycle and encompasses emerging priorities in chronic and noncommunicable disease control. A view in which progress in maternal health is measured merely in terms of survival of childbirth is outmoded. It is time for priorities in women’s health are set in accordance with the unfolding demographic and epidemio- logic transition and with breakthroughs in public health and medicine. Chronic and noncommunicable diseases exem- plify the new and often ignored chal- lenges that are emerging in women’s health. Deaths from breast and cervical cancer have outstripped maternal deaths (273 500 in 2011), which have declined substantially over the past three de- cades.1,2 Over the same period, breast cancer incidence and mortality have increased at annual rates of 3.1% and 1.8%, respectively.2 Furthermore, trends in breast and cervical cancer illustrate the geographical polarization and pro- tracted nature of the epidemiological transition and the overlapping and com- plex challenges facing health systems in the field of women’s health.3,4 In 2010, breast cancer killed 269 000 women in low- and middle-income countries and cervical cancer killed 247 000.5 At the same time, cervical cancer incidence and mortality have become increasingly con- centrated in low- and middle-income countries and hence in women who are poor.6 The same is true of diabetes, car- diovascular diseases, mental disorders and other health conditions. Women´s health in low- and middle- income countries is further complicated by the gender-specific nature of some demographic changes. Although women live longer than men, it is conventionally believed that they experience poorer health. Policies and programmes must therefore address women’s health holisti- cally and from a life-course perspective that focuses on providing women with a continuum of care. A growing evidence base, mainly from high-income coun- tries, on the diseases and disabilities affecting women beyond reproduction supports this approach. Funding is needed to identify gaps in addressing women’s health problems and to foster innovative ways of developing life course interventions.7 More broadly, health systems must target and meet disease-specific pri- orities and systemic challenges syner- gistically, as envisioned in a diagonal approach to health systems strengthen- ing.8 Such an approach avoids the pitfall of classifying diseases into discrete categories and allows the development of common delivery platforms that con- sider shared risk factors across diseases to optimize available resources. To move this agenda forward, more evidence from low- and middle-income countries is needed. This involves taking stock of existing research, conducting new research, capturing a range of ex- periences and initiating a broader, com- munity-engaging dialogue on women’s health with a focus on health systems and on chronic and non-communicable diseases. Through a special theme issue on women’s health beyond reproduction to be published in 2013, the Bulletin is inviting critical assessment of the global challenges involved in women’s health beyond reproduction. We welcome papers that look at the health of women in low- and middle-income countries throughout the lifespan and from a per- spective that embraces gender inequali- ties and social determinants. We wish to encourage the following types of papers in particular: critical appraisals of the opportunities for diagnosing and treat- ing the full range of conditions affecting women (e.g. cancer, cardiovascular dis- eases, diabetes, infertility, incontinence, peri- and post-menopausal disorders, etc.); assessments of health system re- sponses to noncommunicable diseases and chronic illnesses, including mental ailments and age-related disabilities; studies of multi-stakeholder approaches and cost-effective ways to address women’s health needs beyond repro- duction, as well as future trends and projections. The deadline for submis- sions is 1 December 2012. Manuscripts should respect the Bulletin’s Guidelines for Contributors and mention this call for papers in a cover letter. All submis- sions will go through the Bulletin’s peer review process. Please submit to: http:// submit.bwho.org ■ References Available at: http://www.who.int/bulletin/ volumes/90/7/12-103549 Women’s health beyond reproduction: meeting the challenges Flavia Bustreo,a Felicia Marie Knaul,b Afsan Bhadelia,b John Bearda & Islene Araujo de Carvalhoa a World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland. b Harvard Medical School, Boston, United States of America. Correspondence to Islene Araujo de Carvalho (e-mail: araujodecarvalho@who.int). E itorials Editorials Bull World Health Organ 2012;90:478–478A | doi:10.2471/BLT.12.103549 478A 1. Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011;378:1139–65. doi:10.1016/S0140-6736(11)61337-8 PMID:21937100 2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011;378:1461–84. doi:10.1016/S0140- 6736(11)61351-2 PMID:21924486 3. Frenk J, Bobadilla JL, Sepulveda J, Cervantes ML. Health transition in middle-income countries: new challenges for health care. Health Policy Plan 1989;4:29–39. doi:10.1093/heapol/4.1.29 4. Knaul FM, Frenk J, Shulman L; for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. Closing the cancer divide: a blueprint to expand access in low and middle income countries. Boston: Harvard Global Equity Initiative; 2011. 5. Globocan 2008 Cancer Fact Sheet [Internet]. Lyon: International Agency for Research on Cancer; 2012. Available from: http://globocan.iarc.fr/ factsheets/cancers/breast.asp [accessed 18 June 2012]. 6. Knaul F, Bhadelia A, Gralow J, Arreola-Ornelas H, Langer A, Frenk J. Meeting the emerging challenge of breast and cervical cancer in low and middle income countries. Int J Gynaecol Obstet 2012. Forthcoming. 7. Presern C, Bustreo F, Droop J, Fogstad H, Starrs A, Henrik A et al. Keeping promises for women and children. Lancet 2012;379:2125–6. doi:10.1016/ S0140-6736(12)60653-9 PMID:22682450 8. Sepúlveda J, Bustreo F, Tapia R, Rivera J, Lozano R, Oláiz G et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 2006;368:2017–27. doi:10.1016/S0140-6736(06)69569-X PMID:17141709 References